Literature DB >> 18090682

Neuromuscular involvement in nephrogenic systemic fibrosis.

Salah Keyrouz1, Stacy A Rudnicki.   

Abstract

INTRODUCTION: Nephrogenic fibrosing dermopathy causes fibrotic skin changes in the setting of renal failure. Although this condition was initially felt to be limited to the skin, recent studies have described widespread involvement, and the term nephrogenic systemic fibrosis (NSF) has been suggested.
OBJECTIVE: To describe the clinical, electrophysiologic, and pathologic findings in three NSF patients with neuromuscular involvement.
METHODS: Case report.
RESULTS: Three patients developed progressive hardening of the skin and underlying fascia and muscles. Strength was difficult to assess because of limited joint mobility. electromyography/nerve conduction studies suggested involvement of both nerve and muscle. Muscle biopsy demonstrated primarily myopathic changes with variable fibrosis.
CONCLUSION: Neuromuscular involvement occurs in NSF and may be difficult to appreciate clinically because of joint and skin fibrosis.

Entities:  

Mesh:

Year:  2007        PMID: 18090682     DOI: 10.1097/CND.0b013e31815a2f9b

Source DB:  PubMed          Journal:  J Clin Neuromuscul Dis        ISSN: 1522-0443


  4 in total

Review 1.  Nephrogenic systemic fibrosis in liver disease: a systematic review.

Authors:  Sameer M Mazhar; Masoud Shiehmorteza; Chad A Kohl; Michael S Middleton; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2009-12       Impact factor: 4.813

Review 2.  Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents.

Authors:  Jeffrey G Penfield
Journal:  Pediatr Nephrol       Date:  2008-06-10       Impact factor: 3.714

3.  Nephrogenic systemic fibrosis: review of 408 biopsy-confirmed cases.

Authors:  Zhitong Zou; Lin Ma
Journal:  Indian J Dermatol       Date:  2011-01       Impact factor: 1.494

4.  Progressive multifocal fibrosing neuropathy: description of a novel disease.

Authors:  Fabian A Mendoza; Jennifer Bagley; Michael Gochfeld; Marinos C Dalakas; John L Farber; Sergio A Jimenez
Journal:  Acta Neuropathol Commun       Date:  2022-03-16       Impact factor: 7.801

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.